Cytek Biosciences, Inc.
- CTKB
- NASDAQ
- Medical devices
- Flow Cytometry
- Cell Analysis Instruments
$5.25
Quote Oct 19, 2026, 08:00 PM UTC
+0.77%over the last month
Max drawdown −13.8%From 1-month high −13.8%3 months +14.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Cytek Biosciences
Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers.
Where the money comes from
Q2 2026 revenue $78.9M
- Service$46.3M58.7%
- Product$32.6M41.3%
Sector
Healthcare
Industry
Medical devices
Exchange
NASDAQ
Employees
682
Market value
$682.4M
Quote Oct 19
Floor
$4.92
6.3% below price
Resistance
$5.42
3.2% above price
Price vs analyst targets
5 analysts
Lowest target
$4.75Highest target
$5.00
$4.75Highest target
$5.00
- Price $5.25
- Average target $4.88
- Analysts' target range
The price is above even the highest analyst target. Analysts' average target sits about 7% lower.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CTKBPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free